Kulmbach (www.aktiencheck.de) - Shockwave Medical-Aktienanalyse von "Der Aktionär":
Michel Doepke vom Anlegermagazin "Der Aktionär" nimmt in einer aktuellen Aktienanalyse die Aktie…
Johnson & Johnson considers deal for Shockwave Medical (SWAV) – WSJ…
PARIS--(BUSINESS WIRE)--Das französische Pharmaunternehmen Juvisé Pharmaceuticals gibt den Erwerb der weltweiten Vermarktungsrechte für Ponvory® (Ponesimod) von Actelion Pharmaceuticals Ltd. bekannt,…
Johnson & Johnson considers deal to buy Shockwave Medical, WSJ reports…
Join the Xponential class action lawsuit to potentially recover losses. Johnson Fistel LLP, a top law firm, can help you…
…
There arent many guarantees in the equity market, but the dividend payouts of Johnson & Johnson and Abbott Laboratories may…
Johnson Controls executive sells shares worth $11.9k…
NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Reckitt auf "Underperform" mit einem Kursziel von 4000…
Johnson & Johnson (JNJ), der weltgrößte Hersteller von Gesundheitsprodukten, hat kürzlich die FDA-Zulassung für Edurant erhalten und wird in naher…
Johnson & Johnson MedTech and Nvidia are developing new artificial intelligence applications for surgery.…
Dublin, March 18, 2024 (GLOBE NEWSWIRE) -- The "Global Bone Graft and Substitutes Market: Focus on Product, Application,…
Johnson & Johnsons days of being a top healthcare stock could be long gone.…
NEW YORK (dpa-AFX Analyser) - Die kanadische Bank RBC hat die Einstufung für Reckitt auf "Outperform" mit einem Kursziel von…
Das Urteil eines US-Geschworenengerichts gegen die Konzerntochter Mead Johnson hat die Aktien des britischen Konsumgüterkonzerns Reckitt Benckiser am Freitag stark…
LONDON (dpa-AFX) - Das Urteils eines US-Geschworenengerichts gegen die Konzerntochter Mead Johnson hat die Aktien des britischen Konsumgüterkonzerns Reckitt …
Die Aktie von Johnson & Johnson hat im Laufe des vergangenen Jahres eine positive Entwicklung von +8,0% verzeichnet, was im…
…
Todays Research Daily features new research reports on 16 major stocks, including UnitedHealth Group Incorporated (UNH), Johnson & Johnson (JNJ)…
…
The Global Recombinant Vaccine Market Size was Valued at USD 8.2 Billion in 2023 and the Worldwide Recombinant Vaccine Market…
…
At least 21 of the 100 measured metropolitan areas are renting at a discount relative to their long term rental…
Companies covered in this study are Pfizer Inc., Merck & Co., Inc., GlaxoSmithKline plc (GSK), AstraZeneca plc, Novartis AG, Johnson…
Ambrx Biopharma shareholders approve Johnson & Johnson merger…
SAN DIEGO, March 06, 2024 (GLOBE NEWSWIRE) -- Ambrx Biopharma, Inc., (“Ambrx” or the “Company”) (NASDAQ: AMAM), today…
Submission supported by data from Phase 3 PERSEUS study, which showed the daratumumab subcutaneous formulation-based regimen significantly reduced the risk…
Ein Mann hatte gegen J&J wegen einem auf Talkum basierenden Babypuder geklagt. Es hätte bei seiner Frau tödlichen Eierstockkrebs verursacht.…
Major home security systems market participants include ADT, Allegion, Resideo Technologies Inc., Robert Bosch, Johnson Controls, SECOM, and Assa Abloy.…
…
Can Johnson & Johnson stock become a hot buy for growth-focused investors, or is this mainly just a dividend play?…
Can Johnson & Johnson stock become a hot buy for growth-focused investors, or is this mainly just a dividend play?…
Johnson Outdoors sets quarterly cash dividend…
…
RACINE, Wisc., Feb. 29, 2024 (GLOBE NEWSWIRE) -- Johnson Outdoors Inc. (Nasdaq: JOUT), a leading global innovator of…
…
Managements thesis regarding the spinoff is now being tested.…
Stocks Analysis by Investing.com (Damian Nowiszewski) covering: Exxon Mobil Corp, Johnson & Johnson, Johnson & Johnson Co, Exxon Mobil Corporation.…
Johnson Controls stock downgraded at Mizuho, says upside is limited…
Johnson Controls stock downgraded to hold on cyber attack impact…
…
Johnson & Johnson has been a stalwart in the healthcare industry for decades, but has it made for a good…
Johnson & Johnson has been a stalwart in the healthcare industry for decades, but has it made for a good…
Johnson & Johnson has been a stalwart in the healthcare industry for decades, but has it made for a good…
REYKJAVIK, Iceland, Feb. 15, 2024 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the…
…
…
The impact of Steven-Johnson Syndrome on the eyes is particularly prominent, resulting in severe eye pain, light sensitivity, vision loss,…
Todays Research Daily features new research reports on 16 major stocks, including Johnson & Johnson (JNJ), The Walt Disney Company…
The pharmaceutical industry is a major player in the life science sector, responsible for developing and manufacturing the majority of…